BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21990226)

  • 1. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
    Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
    Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.
    Lee BB; Do YS; Byun HS; Choo IW; Kim DI; Huh SH
    J Vasc Surg; 2003 Mar; 37(3):533-8. PubMed ID: 12618688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
    Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
    Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
    Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
    J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
    Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
    Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up.
    James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM
    J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
    Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
    AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
    Su L; Fan X; Zheng L; Zheng J
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
    Kishi K; Morita N; Terada T; Sato M
    Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotherapy of craniofacial venous malformations: complications and results.
    Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
    Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial nerve decompression surgery in patients with temporal bone trauma: analysis of 66 cases.
    Hato N; Nota J; Hakuba N; Gyo K; Yanagihara N
    J Trauma; 2011 Dec; 71(6):1789-92; discussion 1792-3. PubMed ID: 22182890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and complications of sclerotherapy for venous malformations.
    Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
    Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation.
    Lee KB; Kim DI; Oh SK; Do YS; Kim KH; Kim YW
    J Vasc Surg; 2008 Nov; 48(5):1286-91. PubMed ID: 18829241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.